Cost-effectiveness of a post-exposure HIV chemoprophylaxis program for blood exposures in health care workers

Matthew G. Marin, Jaclyn Van Lieu, Albert Yee, Eileen Bonner, Sharon Glied

Research output: Contribution to journalArticle

Abstract

We performed a cost-effectiveness analysis of a post-exposure chemoprophylaxis program for health care workers who sustained exposures to blood. We analyzed a program of (1) treatment with zidovudine alone versus no treatment and (2) treatment with three-drug therapy versus no treatment. Assuming that 35% of exposures were to HIV-positive sources, the zidovudine regimen prevented 53 HIV seroconversions per 100,000 exposures, at a societal cost of $2.0 million per case of HIV prevented. The cost per quality-adjusted life year saved was $175,222. A three-drug chemoprophylactic therapy program (postulating 100 % effectiveness and 35 % source HIV positivity), prevented 66 seroconversions per 100, 000 exposures, at a cost of $2.1 million per case of HIV prevented and $190,392 per quality-adjusted life year saved. Treating sources known to be HIV-positive and treating severe exposures were the most cost-effective strategies.

Original languageEnglish (US)
Pages (from-to)754-760
Number of pages7
JournalJournal of Occupational and Environmental Medicine
Volume41
Issue number9
DOIs
StatePublished - Sep 1999

Fingerprint

Chemoprevention
Cost-Benefit Analysis
HIV
Delivery of Health Care
Costs and Cost Analysis
Quality-Adjusted Life Years
Zidovudine
HIV Seropositivity
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health, Toxicology and Mutagenesis

Cite this

Cost-effectiveness of a post-exposure HIV chemoprophylaxis program for blood exposures in health care workers. / Marin, Matthew G.; Van Lieu, Jaclyn; Yee, Albert; Bonner, Eileen; Glied, Sharon.

In: Journal of Occupational and Environmental Medicine, Vol. 41, No. 9, 09.1999, p. 754-760.

Research output: Contribution to journalArticle

@article{81fc9d945c9148debb49947ad406484e,
title = "Cost-effectiveness of a post-exposure HIV chemoprophylaxis program for blood exposures in health care workers",
abstract = "We performed a cost-effectiveness analysis of a post-exposure chemoprophylaxis program for health care workers who sustained exposures to blood. We analyzed a program of (1) treatment with zidovudine alone versus no treatment and (2) treatment with three-drug therapy versus no treatment. Assuming that 35{\%} of exposures were to HIV-positive sources, the zidovudine regimen prevented 53 HIV seroconversions per 100,000 exposures, at a societal cost of $2.0 million per case of HIV prevented. The cost per quality-adjusted life year saved was $175,222. A three-drug chemoprophylactic therapy program (postulating 100 {\%} effectiveness and 35 {\%} source HIV positivity), prevented 66 seroconversions per 100, 000 exposures, at a cost of $2.1 million per case of HIV prevented and $190,392 per quality-adjusted life year saved. Treating sources known to be HIV-positive and treating severe exposures were the most cost-effective strategies.",
author = "Marin, {Matthew G.} and {Van Lieu}, Jaclyn and Albert Yee and Eileen Bonner and Sharon Glied",
year = "1999",
month = "9",
doi = "10.1097/00043764-199909000-00007",
language = "English (US)",
volume = "41",
pages = "754--760",
journal = "Journal of Occupational and Environmental Medicine",
issn = "1076-2752",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Cost-effectiveness of a post-exposure HIV chemoprophylaxis program for blood exposures in health care workers

AU - Marin, Matthew G.

AU - Van Lieu, Jaclyn

AU - Yee, Albert

AU - Bonner, Eileen

AU - Glied, Sharon

PY - 1999/9

Y1 - 1999/9

N2 - We performed a cost-effectiveness analysis of a post-exposure chemoprophylaxis program for health care workers who sustained exposures to blood. We analyzed a program of (1) treatment with zidovudine alone versus no treatment and (2) treatment with three-drug therapy versus no treatment. Assuming that 35% of exposures were to HIV-positive sources, the zidovudine regimen prevented 53 HIV seroconversions per 100,000 exposures, at a societal cost of $2.0 million per case of HIV prevented. The cost per quality-adjusted life year saved was $175,222. A three-drug chemoprophylactic therapy program (postulating 100 % effectiveness and 35 % source HIV positivity), prevented 66 seroconversions per 100, 000 exposures, at a cost of $2.1 million per case of HIV prevented and $190,392 per quality-adjusted life year saved. Treating sources known to be HIV-positive and treating severe exposures were the most cost-effective strategies.

AB - We performed a cost-effectiveness analysis of a post-exposure chemoprophylaxis program for health care workers who sustained exposures to blood. We analyzed a program of (1) treatment with zidovudine alone versus no treatment and (2) treatment with three-drug therapy versus no treatment. Assuming that 35% of exposures were to HIV-positive sources, the zidovudine regimen prevented 53 HIV seroconversions per 100,000 exposures, at a societal cost of $2.0 million per case of HIV prevented. The cost per quality-adjusted life year saved was $175,222. A three-drug chemoprophylactic therapy program (postulating 100 % effectiveness and 35 % source HIV positivity), prevented 66 seroconversions per 100, 000 exposures, at a cost of $2.1 million per case of HIV prevented and $190,392 per quality-adjusted life year saved. Treating sources known to be HIV-positive and treating severe exposures were the most cost-effective strategies.

UR - http://www.scopus.com/inward/record.url?scp=0032887276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032887276&partnerID=8YFLogxK

U2 - 10.1097/00043764-199909000-00007

DO - 10.1097/00043764-199909000-00007

M3 - Article

VL - 41

SP - 754

EP - 760

JO - Journal of Occupational and Environmental Medicine

JF - Journal of Occupational and Environmental Medicine

SN - 1076-2752

IS - 9

ER -